Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis

BACKGROUND: Several studies have explored the association between the use of proton pump inhibitors (PPIs) and the risk of developing hepatic encephalopathy (HE) in patients with advanced liver disease. However, the evidence-based conclusions are controversial. We hypothesized that using PPIs may in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tantai, Xin-Xing, Yang, Long-Bao, Wei, Zhong-Cao, Xiao, Cai-Lan, Chen, Li-Rong, Wang, Jin-Hai, Liu, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558434/
https://www.ncbi.nlm.nih.gov/pubmed/31210719
http://dx.doi.org/10.3748/wjg.v25.i21.2683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558434/
https://www.ncbi.nlm.nih.gov/pubmed/31210719
http://dx.doi.org/10.3748/wjg.v25.i21.2683

Ejemplares similares